SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUARDIGLI, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.909
EU - Europa 537
AS - Asia 524
SA - Sud America 58
AF - Africa 5
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.036
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.891
CN - Cina 218
SG - Singapore 204
IT - Italia 137
UA - Ucraina 129
DE - Germania 83
TR - Turchia 67
GB - Regno Unito 59
BR - Brasile 46
FI - Finlandia 34
SE - Svezia 30
FR - Francia 13
ID - Indonesia 12
CA - Canada 11
BE - Belgio 7
DK - Danimarca 7
NL - Olanda 7
HK - Hong Kong 6
LT - Lituania 6
VN - Vietnam 6
CO - Colombia 5
IE - Irlanda 4
AT - Austria 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
IN - India 3
RU - Federazione Russa 3
AR - Argentina 2
CH - Svizzera 2
EG - Egitto 2
ES - Italia 2
IQ - Iraq 2
MX - Messico 2
NZ - Nuova Zelanda 2
PE - Perù 2
RO - Romania 2
SV - El Salvador 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CU - Cuba 1
IM - Isola di Man 1
JO - Giordania 1
JP - Giappone 1
KE - Kenya 1
KR - Corea 1
LU - Lussemburgo 1
NI - Nicaragua 1
NO - Norvegia 1
PL - Polonia 1
PT - Portogallo 1
UZ - Uzbekistan 1
Totale 3.036
Salva come PNG Salva come JPEG
Città #
Woodbridge 209
Chandler 174
Santa Clara 171
Fairfield 167
Jacksonville 149
Singapore 144
Houston 123
Ashburn 110
Ann Arbor 88
Wilmington 74
Seattle 65
Nanjing 52
Cambridge 46
Princeton 44
Izmir 43
Shanghai 30
Boardman 27
San Diego 26
Beijing 25
Ferrara 24
Milan 23
New York 22
Bremen 19
Bologna 16
Shenyang 13
Jakarta 12
Falls Church 11
London 11
Jiaxing 8
Nanchang 8
Brussels 7
Changsha 7
Dearborn 7
Hebei 7
Naples 7
Acireale 6
Helsinki 6
Kunming 6
Odense 6
Redwood City 6
Tianjin 6
Toronto 6
Addison 5
Hong Kong 5
Parma 5
San Mateo 5
Falkenstein 4
Jinan 4
Los Angeles 4
Ningbo 4
Orange 4
Poggio Renatico 4
Bogotá 3
Council Bluffs 3
Dublin 3
Edinburgh 3
Mountain View 3
Munich 3
Nuremberg 3
Ottawa 3
Rimini 3
Zhengzhou 3
Aversa 2
Barcelona 2
Brasília 2
Brno 2
Brugherio 2
Bucharest 2
Cairo 2
Des Moines 2
Forest City 2
Frankfurt am Main 2
Goiânia 2
Guangzhou 2
Indiana 2
Lappeenranta 2
Leawood 2
Lima 2
Lugano 2
Norwalk 2
Padova 2
Piacenza 2
Rome 2
San Salvador 2
Sassari 2
São José 2
São Paulo 2
Taizhou 2
Tappahannock 2
Verona 2
Vienna 2
Vigonza 2
Washington 2
Alcobaça 1
Amman 1
Amsterdam 1
Araras 1
Assis 1
Atalaia 1
Atlanta 1
Totale 2.154
Salva come PNG Salva come JPEG
Nome #
Reperfusion Damage - A Story of Success, Failure, and Hope 134
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 120
The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty - The ADVANCE trial 118
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction 109
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium 109
Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 99
Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders 98
The heart rate story 97
Oxidative stress during myocardial ischaemia and heart failure 96
Interventricular dyssynchrony does not identify CRT responders in patients with heart failure 96
Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study 93
Angiotensin II overproduction: enemy of the vessel wall 92
A modern fairy tale 90
Oltre la dissincronia quali fattori determinano la risposta alla terapia di resincronizzazione cardiaca? 88
[Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention] 86
EL PENSAMIENTO NARRATIVO PARA CONTRARRESTAR LAS ENFERMEDADES CARDIOVASCULARES. PRIMEROS RESULTADOS DE UN CAMINO DE PREVENCIÓN SECUNDARIA 85
Tirofiban: a critical reappraisal of the clinical use, recent developpements and future perspectives. 80
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 77
Role of duration of post-stress left ventricular dysfunction in the identification of multivassel coronary artery disease: a Tc-99m sestamibi gated-SPECT study 75
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement 74
CARDIOPROTECTION WITH ACE INHIBITORS: NON-ANGIOTENSIN II-RELATED MECHANISMS 69
Bradykinin and coronary artery disease 68
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 63
Tirofiban, administered at high dose bolus during coronary angioplasty is highly effective in preventing periprocedural ischemic complications in diabetic patients. Insights into the ADVANCE trial. 62
Tessuto adiposo epicardico quale nuovo fattore di rischio cardiovascolare 61
null 61
Ferrara VI 59
CORRENTE IF COME NUOVO TARGET TERAPEUTICO NELL’ANGINA STABILE 58
LEFT VENTRICULAR REMODELLING AT THE LIMITS 54
Safety and efficacy of new-generation coronary bioresorbable scaffolds 54
FERRARA: CITTÀ DELLA PREVENZIONE 53
Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome 51
Heart Rate Variability Relates with Competition Performance in Professional Soccer Players 50
In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study 48
Criteri di appropriatezza nella gestione della terapia ipocolesterolemizzante con alirocumab nel paziente ad alto rischio cardiovascolare. L’opinione di un gruppo multidisciplinare di esperti italiani [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts] 43
Ferrara II 42
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 39
Screening della fibrillazione atriale nella popolazione generale: esperienza della campagna educazionale sul rischio cardiovascolare della Regione Emilia-Romagna [Screening for atrial fibrillation in the general population: experience from a cardiovascular risk campaign in the Emilia-Romagna Region] 38
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge 32
The future of cardiovascular prevention: between fiction and reality 30
Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study 29
P422 CARDIOTOXICITY ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: A CLINICAL CASE 21
MULTIMODALITY IMAGING IN ACROMEGALIC CARDIOMIOPATHY: A CASE REPORT 20
P299 WATCHMAN DEVICE THROMBOSIS FOLLOWING THE PERCUTANEOUS CLOSURE OF THE LEFT ATRIUM APPENDAGE: A "CUL–DE–SAC" IN THE ANTITHROMBOTIC STRATEGY 18
ZERO FLUOROSCOPY CARDIAC ABLATION: A NOVEL WORKFLOW FOR ATRIAL FIBRILLATION 18
P1 ATRIAL TACHYCARDIA IN PATIENT WITH TRANSFUSION–DEPENDENT BETA THALASSEMIA AND SEVERE HEMOCHROMATOSIS: A CASE REPORT 17
P18 ATRIAL FIBRILLATION IN BETA–THALASSAEMIA: PHYSIOPATHOLOGY AND CLINICAL MANAGEMENT 15
One-year outcome of elderly patients with endocarditis: a retrospective observational study 15
A COVID-19 specific multiparametric and ECG-based score for the prediction of in-hospital mortality: ELCOVID score 9
Totale 3.113
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 319
Totale 20.835
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020106 0 0 0 0 0 0 0 0 29 56 13 8
2020/2021311 30 50 10 38 18 28 3 38 7 35 39 15
2021/2022361 11 43 24 13 18 18 15 21 14 25 35 124
2022/2023423 40 10 16 44 84 67 20 41 54 6 34 7
2023/2024282 19 37 10 4 13 47 21 23 5 8 14 81
2024/2025636 23 35 87 71 162 127 44 53 34 0 0 0
Totale 3.113